BRIEF-Amarin's says 100 pct Mark reached on REDUCE-IT Cardiovascular Outcomes Study for Estimated Onset of Target Primary MACE

April 4 (Reuters) - Amarin Corporation PLC:

* IT CARDIOVASCULAR OUTCOMES STUDY REACHES 100% MARK FOR ESTIMATED ONSET OF TARGET PRIMARY MAJOR ADVERSE CARDIOVASCULAR EVENTS

* MAINTAINS ITS GUIDANCE TO REPORT TOP-LINE RESULTS FROM STUDY BEFORE END OF Q3 2018. Source text for Eikon: Further company coverage: